from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. A drug that may be used to treat decreased libido in women


Sorry, no etymologies found.


  • Originally studied as a possible antidepressant, flibanserin is the latest attempt by the drug industry to find a female equivalent to Viagra.

    Boehringer Halts Development of 'Female Viagra'

  • And it was an article from the awesome Dr. Petra which notified Sci of the current stuff going on with this drug called flibanserin, which has to be one of the WORST drug names.

    ScienceBlogs Channel : Life Science

  • On June 18, a drug called flibanserin, intended to treat low female desire, was rejected by an FDA advisory panel on the grounds that the benefits of the drug did not outweigh the risks.

  • • There may be new hope for women with low sexual desire, thanks to a new drug called flibanserin that was originally developed as an antidepressant.


  • The new product, known as flibanserin, would be the first of its kind to help women who suffer from little or no sexual desire, said Dr. Irwin Goldstein, director of the Sexual Medicine Program at Alvarado Hospital in San Diego and a consultant to Boehringer Ingelheim.

    The Washington Times stories: Latest Headlines

  • New drug boosts women's sex drive drug called flibanserin as a possible remedy for sexual dysfunction in depression, the pill was later found to increase the ...


  • Before everyone jumps on the hype bandwagon by calling flibanserin a female sexual dysfunction "the female Viagra" … oops, it's too late. - Articles related to New Drug May Be Female Viagra

  • The experimental drug, called flibanserin, was ... - Articles related to New Drug May Be Female Viagra

  • A German pharmaceutical giant wants to sell a drug with the decidedly unsexy name "flibanserin," which has shown prowess for sparking a woman's sexual desire by fiddling with her brain chemicals.

    FDA considers endorsement of drug that some call a Viagra for women

  • The German pharmaceutical company Boehringer Engelheim announced Friday afternoon that it was ceasing research on its one-a-day oral pill containing flibanserin, dubbed "pink Viagra" for its potential to help women with low sex drive boost their sexual desire.

    Company drops effort to develop 'pink Viagra'


Log in or sign up to get involved in the conversation. It's quick and easy.